Xellia Pharmaceuticals ApS Sustainability Reports
Xellia Pharmaceuticals ApS develops and manufactures anti-infective treatments and active pharmaceutical ingredients. It specializes in addressing serious or life-threatening infections, including multi-drug resistant strains.
Sector: Manufacturing
Country: Denmark
Exchange: Unlisted
LEI: 549300QZH7QG20ETC156
1 reports from 2025 to 2025